Daclizumab trial for relapsing-remitting MS begins

If it's on your mind and it has to do with multiple sclerosis in any way, post it here.
Post Reply
User avatar
MSUK
Family Elder
Posts: 2903
Joined: 9 years ago
Contact:

Daclizumab trial for relapsing-remitting MS begins

Post by MSUK » 8 years ago

Image

Active Comparator Study Designed to Examine the Safety and Efficacy of Daclizumab Formulated for Monthly Subcutaneous Dosing.

Biogen Idec and Abbott today announced enrollment of the first patient in a global Phase III study evaluating the efficacy and safety of daclizumab compared to to interferon beta-1a (Avonex(R)) in patients with relapsing-remitting multiple sclerosis (RRMS), the most common form of multiple sclerosis (MS).. [Read More - http://www.msrc.co.uk/index.cfm/fuseact ... ageid/1502]
MS-UK - http://www.ms-uk.org/

User avatar
ssmme
Family Elder
Posts: 357
Joined: 11 years ago
Location: Lexington, KY
Contact:

Post by ssmme » 8 years ago

It appears that this drug is to be taken monthly along with the weekly, every other day, or every three day interferon shots. It's a disappointment that it doesn't replace them.
Marcia

Post Reply
  • Similar Topics
    Replies
    Views
    Last post